Joakim Nordanstig: SWEDEPAD Data Show Early Risk Of Limb Loss With Paclitaxel-Coated Devices
Joakim Nordanstig, President at Swedish Society for Vascular Surgery (SSVS), shared a post on LinkedIn:
”Very honoured to have been invited to the absolutely amazing Charing Cross Vascular and Endovascular Consensus Meeting in London this week.
Today, we provided data updates from the SWEDEPAD trials, including a detailed subgroup analysis in Rutherford 5-6 patients from SWEDEPAD 1, demonstrating an increased early risk for limb loss in patients treated with paclitaxel-coated devices compared to uncoated devices.
This observation may explain to overall neutral results in terms of major amputation rates (the primary endpoint) previously reported from SWEDEPAD 1. My colleague (dr Mårten Falkenberg) also presented important cause-specific mortality rate data from both SWEDEPAD 1 and 2 in an effort to better understand the late mortality signal noted with paclitaxel-coated devices.
We also presented vessel segment-specific data, showing that the previously reported reduced TVR rates with paclitaxel-coated devices was mainly driven by interventions in the femoropopliteal segment, whereas results were neutral infrapopliteally.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026